TY - JOUR T1 - Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020. AU - Bushman,Dena, AU - Alroy,Karen A, AU - Greene,Sharon K, AU - Keating,Page, AU - Wahnich,Amanda, AU - Weiss,Don, AU - Pathela,Preeti, AU - Harrison,Christy, AU - Rakeman,Jennifer, AU - Langley,Gayle, AU - Tong,Suxiang, AU - Tao,Ying, AU - Uehara,Anna, AU - Queen,Krista, AU - Paden,Clinton R, AU - Szymczak,Wendy, AU - Orner,Erika P, AU - Nori,Priya, AU - Lai,Phi A, AU - Jacobson,Jessica L, AU - Singh,Harjot K, AU - Calfee,David P, AU - Westblade,Lars F, AU - Vasovic,Ljiljana V, AU - Rand,Jacob H, AU - Liu,Dakai, AU - Singh,Vishnu, AU - Burns,Janice, AU - Prasad,Nishant, AU - ,, AU - Sell,Jessica, Y1 - 2020/07/17/ PY - 2020/7/18/entrez PY - 2020/7/18/pubmed PY - 2020/7/21/medline SP - 918 EP - 922 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 69 IS - 28 N2 - To limit introduction of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), the United States restricted travel from China on February 2, 2020, and from Europe on March 13. To determine whether local transmission of SARS-CoV-2 could be detected, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) conducted deidentified sentinel surveillance at six NYC hospital emergency departments (EDs) during March 1-20. On March 8, while testing availability for SARS-CoV-2 was still limited, DOHMH announced sustained community transmission of SARS-CoV-2 (1). At this time, twenty-six NYC residents had confirmed COVID-19, and ED visits for influenza-like illness* increased, despite decreased influenza virus circulation.† The following week, on March 15, when only seven of the 56 (13%) patients with known exposure histories had exposure outside of NYC, the level of community SARS-CoV-2 transmission status was elevated from sustained community transmission to widespread community transmission (2). Through sentinel surveillance during March 1-20, DOHMH collected 544 specimens from patients with influenza-like symptoms (ILS)§ who had negative test results for influenza and, in some instances, other respiratory pathogens.¶ All 544 specimens were tested for SARS-CoV-2 at CDC; 36 (6.6%) tested positive. Using genetic sequencing, CDC determined that the sequences of most SARS-CoV-2-positive specimens resembled those circulating in Europe, suggesting probable introductions of SARS-CoV-2 from Europe, from other U.S. locations, and local introductions from within New York. These findings demonstrate that partnering with health care facilities and developing the systems needed for rapid implementation of sentinel surveillance, coupled with capacity for genetic sequencing before an outbreak, can help inform timely containment and mitigation strategies. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/32678072/Detection_and_Genetic_Characterization_of_Community_Based_SARS_CoV_2_Infections___New_York_City_March_2020_ DB - PRIME DP - Unbound Medicine ER -